Keith R. McCrae
Taylor & Francis, 6 במרץ 2006 - 336 עמודים
The first and only source to offer an all-encompassing approach to the pathogenesis and treatment of thrombocytopenic disorders, this book reviews current information concerning thrombocytopenia due to diminished platelet production and accelerated immunologic and nonimmunologic platelet clearance, as well as a detailed review of medications that cause this disorder.
Biology and Potential Clinical
12 קטעים אחרים שאינם מוצגים
מהדורות אחרות - הצג הכל
activation acute ADAMTS13 addition adults alloimmune anemia antibodies antigens appears assay associated autoimmune binding bleeding Blood bone marrow cause cells chronic circulating Clin clinical common complex complications considered deficiency demonstrated detection diagnosis disease disorders donor dose drug effect et al evidence expression factor fetal function gene given glycoprotein growth Haematol hemorrhage heparin heparin-induced thrombocytopenia human idiopathic thrombocytopenic purpura immune immune thrombocytopenic important increased individuals induced infection intravenous involved less leukemia levels maternal mechanisms megakaryocyte mice neonatal normal observed occur patients plasma platelet count platelet production platelet transfusions pregnancy present protein reactions recent receptor recombinant reduced refractory renal reported response risk role sensitivity severe specific suggest syndrome Table testing therapy thrombocytopenia thrombocytopenic purpura thrombopoietin thrombosis thrombotic microangiopathy thrombotic thrombocytopenic purpura transplantation treated treatment trial usually